Orthobiologics Market: Global Industry Size, Opportunities, Share, Trends, Growth, Demand and Forecast 2018-2026

Credence Research recently published a research study on Orthobiologics Market By Product Type (Viscosupplementation, Demineralized Bone Matrices, Synthetic Orthobiologics, Bone Morphogenic Protein, Allografts, Plasma-Rich Protein, Bone Marrow Aspirate Concentrate), By Application (Osteoarthritis And Degenerative Arthritis, Spinal Fusion, Soft-Tissue Injuries, Fracture Recovery, Maxillofacial And Dental Applications)

In the latest market report issued by Credence Research, Inc. “Orthobiologics Market - Growth, Future Prospects, Competitive Analysis, 2018 - 2026,” the global Orthobiologics market was expected at US$ 4,919.0 Mn in 2017 increasing at a CAGR of 5.7% from 2018 to 2026.

Market Insights:
Orthobiologics is a minimally invasive system using the biological substance to fasten the healing process when an injury. Orthobiologics have shown to better healing of musculoskeletal injuries such as injured muscle, fractures, ligaments and tendons. Orthobiologics include a range of treatment using patient’s own tissue or stem cells to produce proteins in order to artificially regenerate injured muscles.

Get Full Report @ https://www.credenceresearch.com/report/orthobiologics-market

There has been a heightened usage of Orthobiologics in the last two decades due to a better understanding of biologics, technological advancements, and skills required for the treatment; thus emerging as a significant sector in shaping the future of regenerative medicines and cellular therapies. Moreover, the growing application of orthobiologics in osteoarthritis and sports medicine is the major driver for the growth of the market. Other factors that are supporting the growth of the orthobiologics market include the growing geriatric population susceptible to orthopedic disorders, the growing rate of obesity and musculoskeletal injuries and increasing patient inclination towards minimally invasive therapies. However, the high costs associated with treatment and products are the prime factor restraining the growth of the global orthobiologics market.

Osteoarthritis Prevalence to Drive Orthobiologics Market

In 2017, osteoarthritis and degenerative arthritis held the largest share in the global orthobiologics market owing to rise in target population suffering from degenerative arthritis, growing public awareness regarding side effects of continuous oral medications, and the introduction of products with better clinical outcome in osteoarthritis management. Spinal fusion segment is predicted to exhibit the fastest growth rate during the forecast period owing to the increase in the number of spinal fusion surgeries globally. American Academy of Orthopedic Surgeons (AAOS) suggests that a total of 0.46 million spinal fusion surgeries was performed in the U.S. in 2011. The advent of minimally invasive surgeries has further boosted the successful outcomes of spinal surgeries. Demand for bone grafts and stem cells have soared high owing to the growing number of orthopedic procedures; consequently pushing the orthobiologics market.

North America Held the Pole Position in Global Orthobiologics Market

By Product Type (2016–2026; US$ Mn)
• Synthetic Orthobiologics
• Bone Morphogenic Protein
• Allografts
• Plasma-Rich Protein
• Viscosupplementation Products
• Demineralized Bone Matrices
• Bone Marrow Aspirate Concentrate

By Application Type (2016–2026; US$ Mn)
• Spinal Fusion
• Soft-Tissue Injuries
• Osteoarthritis and Degenerative Arthritis
• Fracture Recovery
• Maxillofacial and Dental Applications

Get Full Report @ https://www.credenceresearch.com/report/orthobiologics-market

ToC:
Chapter 1. Preface
Chapter 2. Executive Summary
Chapter 3. Orthobiologics: Market Dynamics and Outlook
Chapter 4. Global Orthobiologics Market, by Product Type, 2016-2026 (US$ Mn)
4.1. Overview
4.2. Viscosupplementation Products
4.3. Demineralized Bone Matrices
4.4. Synthetic Orthobiologics
4.5. Bone Morphogenic Protein
4.6. Allografts
4.7. Plasma-Rich Protein
4.8. Bone Marrow Aspirate Concentrate
Chapter 5. Global Orthobiologics Market, by Application, 2016-2026 (US$ Mn)
5.1. Overview
5.2. Osteoarthritis and Degenerative Arthritis
5.3. Spinal Fusion
5.4. Soft-Tissue Injuries
5.5. Fracture Recovery
5.6. Maxillofacial and Dental Applications
Chapter 6. Global Orthobiologics Market, by Geography, 2016 – 2026 (US$ Mn)
6.1. North America Orthobiologics Market Analysis, 2016 – 2026
6.1.1. North America Orthobiologics Market, by Product Type, 2016 - 2026 (US$ Mn)
6.1.2. North America Orthobiologics Market, by Application, 2016 - 2026 (US$ Mn)
6.1.3. North America Orthobiologics Market, by Country, 2016 – 2026 (US$ Mn)
6.1.3.1. The U.S.
6.1.3.2. Canada
6.2. Europe Orthobiologics Market Analysis, 2016 – 2026
6.2.1. Europe Orthobiologics Market, by Product Type, 2016 - 2026 (US$ Mn)
6.2.2. Europe Orthobiologics Market, by Application, 2016 - 2026 (US$ Mn)
6.2.3. Europe Orthobiologics Market, by Country, 2016 – 2026 (US$ Mn)
6.2.3.1. U.K.
6.2.3.2. Germany
6.2.3.3. Rest of Europe
6.3. Asia Pacific Orthobiologics Market Analysis, 2016 – 2026
6.3.1. Asia Pacific Orthobiologics Market, by Product Type, 2016 - 2026 (US$ Mn)
6.3.2. Asia Pacific Orthobiologics Market, by Application, 2016 - 2026 (US$ Mn)
6.3.3. Asia Pacific Orthobiologics Market, by Country, 2016 – 2026 (US$ Mn)
6.3.3.1. China
6.3.3.2. Japan
6.3.3.3. India
6.3.3.4. Rest of Asia Pacific
6.4. Latin America Orthobiologics Market Analysis, 2016 – 2026
6.4.1. Latin America Orthobiologics Market, by Product Type, 2016 - 2026 (US$ Mn)
6.4.2. Latin America Orthobiologics Market, by Application, 2016 - 2026 (US$ Mn)
6.4.3. Latin America Orthobiologics Market, by Country, 2016 – 2026 (US$ Mn)
6.4.3.1. Brazil
6.4.3.2. Mexico
6.4.3.3. Rest of Latin America
6.5. The Middle East & Africa Orthobiologics Market, 2016 – 2026
6.5.1. Middle East & Africa Orthobiologics Market, by Product Type, 2016 - 2026 (US$ Mn)
6.5.2. Middle East & Africa Orthobiologics Market, by Application, 2016 - 2026 (US$ Mn)
6.5.3. Middle East & Africa Orthobiologics Market, by Country, 2016 – 2026 (US$ Mn)
6.5.3.1. GCC
6.5.3.2. Rest of Middle East & Africa

Get Full Report @ https://www.credenceresearch.com/report/orthobiologics-market

About Us:
Credence Research is a worldwide market research and counseling firm that serves driving organizations, governments, non legislative associations, and not-for-benefits. We offer our customers some assistance with making enduring enhancements to their execution and understand their most imperative objectives. Over almost a century, we've manufactured a firm extraordinarily prepared to this task.

Contact Info:
Name: Chris Smith
Email: Send Email
Organization: Credence Research
Address: 105 N 1st ST #429, SAN JOSE,, CA 95103, United States
Phone: 18003618290
Website: https://www.credenceresearch.com/report/orthobiologics-market

Release ID: 447165